Graphite Bio

Graphite Bio is a clinical-stage next-generation gene editing company that leverages efficient targeted gene integration to develop a new class of therapies with the potential to cure a variety of severe and life-threatening diseases, focusing on developing first-class treatments for patients with life-threatening genetic disorders. The company's platform harnesses the natural cellular process of homology-directed repair (HDR) and targeted DNA integration to precisely repair genetic defects at their source. Graphite Bio is utilizing its differentiated platform to advance a transformative portfolio of gene therapies aimed at saving and significantly improving patients' lives.